AQR Arbitrage LLC Grows Stake in Amedisys, Inc. (NASDAQ:AMED)

AQR Arbitrage LLC grew its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 59.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 471,965 shares of the health services provider's stock after buying an additional 175,311 shares during the quarter. Amedisys accounts for about 0.9% of AQR Arbitrage LLC's portfolio, making the stock its 22nd largest holding. AQR Arbitrage LLC owned about 1.44% of Amedisys worth $42,812,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of AMED. Blue Trust Inc. raised its position in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares during the last quarter. Xponance Inc. increased its position in shares of Amedisys by 3.5% during the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after purchasing an additional 148 shares in the last quarter. Inspire Investing LLC lifted its holdings in Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock valued at $400,000 after purchasing an additional 155 shares in the last quarter. Gamco Investors INC. ET AL grew its holdings in shares of Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after buying an additional 159 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock worth $1,375,000 after buying an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on AMED. Royal Bank of Canada restated an "outperform" rating and issued a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th. Stephens restated an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, Amedisys presently has a consensus rating of "Hold" and an average price target of $100.75.

Amedisys Stock Performance

NASDAQ AMED traded up $0.25 on Monday, hitting $96.25. 629,698 shares of the company's stock were exchanged, compared to its average volume of 414,460. The firm has a market cap of $3.16 billion, a price-to-earnings ratio of 38.19, a P/E/G ratio of 1.78 and a beta of 0.96. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The firm's 50-day moving average price is $92.58 and its two-hundred day moving average price is $91.70. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same quarter in the prior year, the firm earned $1.03 EPS. Amedisys's quarterly revenue was up 4.1% on a year-over-year basis. On average, research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.